|
1 Indications And Usage Livalo Is Indicated As An Adjunctive Therapy To Diet In: Adult Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia To Reduce Elevated Total Cholesterol (Tc), Low-Density Lipoprotein Cholesterol (Ldl-C), Apolipoprotein B (Apo B), Triglycerides (Tg), And To Increase High-Density Lipoprotein Cholesterol (Hdl-C). Pediatric Patients Aged 8 Years And Older With Heterozygous Familial Hypercholesterolemia (Hefh) To Reduce Elevated Tc, Ldl-C, And Apo B. Limitations Of Use The Effect Of Livalo On Cardiovascular Morbidity And Mortality Has Not Been Determined. Livalo Is A Hmg-Coa Reductase Inhibitor Indicated As An Adjunctive Therapy To Diet In: Adult Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia To Reduce Elevated Total Cholesterol (Tc), Low-Density Lipoprotein Cholesterol (Ldl-C), Apolipoprotein B (Apo B), Triglycerides (Tg), And To Increase High-Density Lipoprotein Cholesterol (Hdl-C) ( 1 ). Pediatric Patients Aged 8 Years And Older With Heterozygous Familial Hypercholesterolemia (Hefh) To Reduce Elevated Tc, Ldl-C, And Apo B ( 1 ). Limitations Of Use: The Effect Of Livalo On Cardiovascular Morbidity And Mortality Has Not Been Determined.
|